Pemphigus Vulgaris and Mucous Membrane Pemphigoid

A blister in the mouth can be the first warning of a systemic autoimmune disease, and two disorders deserve particular attention in the dental chair: pemphigus vulgaris and mucous membrane pemphigoid. Both produce chronic oral ulceration, yet their immunologic targets, clinical behavior and long-...

A blister in the mouth can be the first warning of a systemic autoimmune disease, and two disorders deserve particular attention in the dental chair: pemphigus vulgaris and mucous membrane pemphigoid. Both produce chronic oral ulceration, yet their immunologic targets, clinical behavior and long-term prognosis are entirely different. Recognizing the differences is essential, because a delayed diagnosis can allow pemphigus to become life-threatening while pemphigoid silently destroys vision and swallowing.

Two Autoimmune Mechanisms

Pemphigus vulgaris: antibodies against desmoglein

Pemphigus vulgaris is an autoimmune disease in which immunoglobulin G autoantibodies attack desmoglein 1 and desmoglein 3, the desmosomal adhesion proteins that hold keratinocytes together. The antibody binding disrupts cell-to-cell adhesion, producing acantholysis, the separation of individual epithelial cells. Because the split occurs within the epithelium, the resulting blisters are fragile and rupture easily, leaving extensive raw erosions rather than intact bullae.

Mucous membrane pemphigoid: antibodies against the basement membrane

Mucous membrane pemphigoid, formerly called cicatricial pemphigoid, is caused by autoantibodies directed against components of the epithelial basement membrane, including the BP180 and BP230 antigens and laminin 332. The antibodies trigger complement activation and inflammatory destruction of the basement membrane zone, so the tissue split occurs beneath the epithelium, leaving the full epithelial thickness as a roof. This subepithelial split produces relatively tense blisters that are less fragile than those of pemphigus.

Why the distinction matters

The level of the split determines the clinical phenotype and the danger profile. Pemphigus can progress to widespread exfoliation, fluid loss and infection, while pemphigoid tends to heal with scarring, and its most dangerous target is the conjunctiva, where fibrosis can cause blindness. Both diseases demand prompt diagnosis and coordinated specialist care.

Oral Manifestations

Pemphigus in the mouth

The oral cavity is the presenting site in roughly half to two-thirds of patients with pemphigus vulgaris, and the disease often begins with painful erosions of the buccal mucosa, palate and gingiva. Intact blisters are rarely seen because they rupture within hours, leaving irregular, bleeding ulcers with ragged epithelial remnants, and a positive Nikolsky sign is often present.

Pemphigoid in the mouth

Mucous membrane pemphigoid produces desquamative gingivitis, a diffuse erythema and peeling of the attached gingiva, together with blisters and erosions of the buccal mucosa and palate. The blisters are often intact when examined because the subepithelial split yields a sturdier roof, and they fill with clear fluid before breaking down. Pain is variable and may be mild despite widespread erythema, which is why some patients tolerate the condition for years before seeking care.

Extending beyond the mouth

Pemphigus vulgaris frequently spreads to the skin, scalp and other mucosae, while mucous membrane pemphigoid classically involves the conjunctiva, nasopharynx, larynx, esophagus and genital mucosa. Ocular involvement, with symblepharon formation and eventual blindness, occurs in a substantial proportion of patients with pemphigoid and may develop even when oral lesions are mild. Dermatologic and ophthalmologic evaluation should therefore accompany any oral diagnosis.

Diagnosis

Clinical clues and provocative signs

The combination of chronic, painful oral erosions with a positive Nikolsky sign strongly suggests an autoimmune blistering disease. In pemphigoid, intact blisters that persist for more than a day point toward a subepithelial process, while in pemphigus the rapid rupture of blisters and the sheer extent of erosion are characteristic. The clinician should photograph the lesions, record their distribution and refer promptly for biopsy rather than attempting empirical treatment.

Biopsy and direct immunofluorescence

The diagnosis is confirmed by biopsy of an early lesion and perilesional tissue, examined with routine histology and direct immunofluorescence. Pemphigus shows acantholysis and intraepithelial cleavage with immunoglobulin G and C3 deposited in the intercellular spaces, giving a fishnet pattern. Mucous membrane pemphigoid shows a subepithelial split with linear deposition of immunoglobulin G, C3 and sometimes immunoglobulin A along the basement membrane zone.

Serologic testing

Indirect immunofluorescence on serum detects circulating autoantibodies, and enzyme-linked immunosorbent assays for desmoglein 1 and 3 confirm pemphigus, while assays for BP180, BP230 and laminin 332 support pemphigoid. These tests also exclude mimics such as lupus erythematosus and dermatomyositis, which can present with oral ulceration but have different immunologic profiles.

Treatment

Pemphigus management

Pemphigus vulgaris is treated with systemic corticosteroids as the cornerstone, usually prednisone at 1 mg per kilogram daily, combined with steroid-sparing agents such as azathioprine, mycophenolate mofetil or rituximab. Rituximab has transformed outcomes and is now a first-line option in many centers, with clinical trials showing durable remissions. Treatment is continued for months to years, with slow tapering guided by disease activity and antibody titers, and patients require monitoring for steroid toxicity and infection.

Pemphigoid management

Mucous membrane pemphigoid is managed with topical corticosteroids for limited oral disease, often with potent gels and mouthwashes, and systemic therapy when lesions are widespread or ocular involvement threatens. Dapsone and sulfapyridine are frequently used, sometimes with low-dose corticosteroids, while mycophenolate and rituximab are reserved for refractory or ocular disease. Because scarring is irreversible, aggressive early control is the priority, and ophthalmologic review is mandatory.

The dental role

The dentist plays a diagnostic and supportive role: recognizing the lesions, obtaining an early biopsy, managing pain and maintaining oral hygiene without traumatizing fragile mucosa. Elective procedures are deferred during active flares, and after remission the gingiva remains delicate and must be handled with minimal trauma.

Daily Care for Fragile Mucosa

Avoiding trauma

Patients should avoid hard, spicy or abrasive food during flares, and alcohol-free rinses and bland topical anesthetics can reduce discomfort. Any instrument or toothbrush that abrades the mucosa risks new erosions, so the hygiene routine must be adapted to the disease stage.

Gentle brushing that protects tissue

A pressure-sensing electric toothbrush such as the BrushO automatically reduces motor power when brushing force becomes excessive, which is exactly what a patient with desquamative gingivitis needs. Its soft bristles and two-minute timer with quadrant guidance remove plaque efficiently while sparing the fragile epithelium. During flares, patients can use the lowest power setting, and as remission is achieved they maintain the same protective routine that keeps the gingiva healthy without provoking new blisters.

Conclusion

Pemphigus vulgaris and mucous membrane pemphigoid are two autoimmune blistering diseases that often announce themselves in the mouth. Pemphigus splits within the epithelium, producing fragile erosions that can become life-threatening if untreated, while pemphigoid splits beneath it, causing scarring that threatens vision and swallowing. Early recognition, biopsy with immunofluorescence, and coordinated treatment with corticosteroids and immunomodulators transform the prognosis, and gentle daily oral care keeps the fragile mucosa stable for years.

（本文由 BrushO 智能牙刷团队撰写，仅供科普参考，不构成医疗建议。）（内容由AI生成，仅供参考）